BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 817791)

  • 1. Waldenström's macroglobulinemia: review of 45 cases.
    Krajny M; Pruzanski W
    Can Med Assoc J; 1976 May; 114(10):899-900, 902, 905. PubMed ID: 817791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit.
    Kyrtsonis MC; Vassilakopoulos TP; Angelopoulou MK; Siakantaris P; Kontopidou FN; Dimopoulou MN; Boussiotis V; Gribabis A; Konstantopoulos K; Vaiopoulos GA; Fessas P; Kittas C; Pangalis GA
    Ann Hematol; 2001 Dec; 80(12):722-7. PubMed ID: 11797112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical studies in a patient with Waldenstrom's macroglobulinemia.
    Mir-Ahmadian M; Rahbar S; Heidery H; Hajaliloo G
    Acta Med Iran; 1978; 21(1):39-46. PubMed ID: 110036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell malignant lymphoma associated with monoclonal macroglobulinemia and cryoglobulinemia.
    Nozaki H; Tanaka K; Shimizu M; Komatsuda M; Tsutsumi Y; Arimori S
    Tokai J Exp Clin Med; 1988 Dec; 13(4-5):245-51. PubMed ID: 3151523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effective treatment with rituximab in two patients with Waldenström macroglobulinemia].
    Yoshimi A; Arai S; Iijima K; Iki S; Usuki K; Urabe A
    Rinsho Ketsueki; 2005 Oct; 46(10):1109-13. PubMed ID: 16440772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Kyle RA; Treon SP; Alexanian R; Barlogie B; Björkholm M; Dhodapkar M; Lister TA; Merlini G; Morel P; Stone M; Branagan AR; Leblond V
    Semin Oncol; 2003 Apr; 30(2):116-20. PubMed ID: 12720119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [IgM myeloma].
    Roujeau JC; Bisson M; Segond P; Massias P
    Sem Hop; 1976 Nov; 52(40):2277-82. PubMed ID: 188179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia.
    Treon SP; Agus TB; Link B; Rodrigues G; Molina A; Lacy MQ; Fisher DC; Emmanouilides C; Richards AI; Clark B; Lucas MS; Schlossman R; Schenkein D; Lin B; Kimby E; Anderson KC; Byrd JC
    J Immunother; 2001; 24(3):272-9. PubMed ID: 11394506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic spectrum of Waldenström's macroglobulinemia: a single center experience.
    Sajid R; Siddiqui SH; Shaikh U; Adil S
    Indian J Pathol Microbiol; 2010; 53(3):490-3. PubMed ID: 20699509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Waldenström's macroglobulinemia: a clinicopathologic study of 22 cases.
    Andriko JA; Aguilera NS; Chu WS; Nandedkar MA; Cotelingam JD
    Cancer; 1997 Nov; 80(10):1926-35. PubMed ID: 9366295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders.
    Pangalis GA; Kyrtsonis MC; Kontopidou FN; Vassilakopoulos TP; Siakantaris MP; Dimopoulou MN; Kittas C; Angelopoulou MK
    Semin Oncol; 2003 Apr; 30(2):201-5. PubMed ID: 12720136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal gammapathies. (Critical review of 219 cases collected over 3 years)].
    Youinou P; Le Goff P; Saleun JP; Jouquan J; Tymen G; Le Menn G
    Pathol Biol (Paris); 1977 Oct; 25(8):517-21. PubMed ID: 413086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma followed by Waldenström's macroglobulinemia: a case report.
    Hasegawa K; Kubota K; Hirai H; Imai Y; Midorikawa Y; Makuuchi M
    Hepatogastroenterology; 2000; 47(33):842-5. PubMed ID: 10919044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM monoclonal gammopathy/Waldenström's macroglobulinemia: a morphological and immunophenotypic study of the bone marrow.
    Feiner HD; Rizk CC; Finfer MD; Bannan M; Gottesman SR; Chuba JV; Amorosi E
    Mod Pathol; 1990 May; 3(3):348-56. PubMed ID: 2114024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of pulmonary Waldenstrom's macroglobulinemia].
    Nii Y; Ogushi F; Satou K; Sone S; Ozaki T; Kobayashi H; Yasuoka S; Ogura T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Jun; 26(6):670-3. PubMed ID: 3149384
    [No Abstract]   [Full Text] [Related]  

  • 16. M components-a review of 1242 cases.
    Ameis A; Ko HS; Pruzanski W
    Can Med Assoc J; 1976 May; 114(10):889-92, 895. PubMed ID: 817789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.
    Weber D; Treon SP; Emmanouilides C; Branagan AR; Byrd JC; Bladé J; Kimby E
    Semin Oncol; 2003 Apr; 30(2):127-31. PubMed ID: 12720121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
    Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
    Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Waldenström's macroglobulinemia].
    Tsuruoka N
    Nihon Rinsho; 1995 Mar; 53(3):725-9. PubMed ID: 7699913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of immunoblastic sarcoma in Waldenstrom's macroglobulinemia.
    Leonhard SA; Muhleman AF; Hurtubise PE; Martelo OJ
    Cancer; 1980 Jun; 45(12):3102-7. PubMed ID: 6770989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.